Androgenic alopecia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Androgenic alopecia Classification and external resources | |
 | |
|---|---|
| Male pattern baldness in a 40 year old man. | |
| ICD-10 | L64. |
| DiseasesDB | 7773 |
| eMedicine | derm/21 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Androgenic alopecia (also known as androgenetic alopecia or alopecia androgenetica) is a common form of hair loss in both men and women. In men, this condition is also known as male-pattern baldness. Hair is lost in a well-defined pattern, beginning above both temples. Over time, the hairline recedes to form a characteristic "M" shape. Hair also thins at the crown of the head, often progressing to partial or complete baldness.
The pattern of hair loss in women differs from male-pattern baldness. In women, the hair becomes thinner all over the head, and the hairline does not recede. Androgenetic alopecia in women rarely leads to total baldness.
A variety of genetic and environmental factors likely play a role in causing androgenetic alopecia. Although researchers are studying risk factors that may contribute to this condition, most of these factors remain unknown. Researchers have determined that this form of hair loss is related to hormones called androgens, particularly an androgen called dihydrotestosterone (DHT). Androgens are important for normal male sexual development before birth and during puberty. Androgens also have other important functions in both males and females, such as regulating hair growth and sex drive.
Hair loss and genetics
Researchers suspect that several genes inherited from both parents play a role in androgenetic alopecia. Paternal hair loss has been shown to correlate with chances of alopecia in sons, while variations in the androgen receptor gene (AR), which can also correlate with baldness, are X linked and thus inherited from one's maternal grandfather or grandmother.
Androgen receptors allow the body to respond appropriately to dihydrotestosterone and other androgens. Studies suggest that variations in the AR gene lead to increased activity of androgen receptors in hair follicles. It remains unclear, however, how these genetic changes increase the incidence of patterned hair loss in men and women with androgenetic alopecia.
The inheritance pattern of androgenetic alopecia is unclear because many genetic and environmental factors are likely to be involved. This condition tends to cluster in families, however, and having a close relative with patterned hair loss appears to be a risk factor for developing the condition.
Hormone levels correlated with androgenetic alopecia
Men with androgenic alopecia typically have lower levels of total testosterone, higher levels of unbound/free testosterone, and higher levels of total free androgens including DHT.[1][2]
5-alpha-reductase is responsible for converting free testosterone into DHT. The genes for 5alpha-reductase are known[3]. The enzymes are present predominantly in the scalp and prostate. Levels of 5alpha-reductase are one factor in determining levels of DHT in the scalp and drugs which interfere with 5alpha-reductase (such as finasteride, which inhibits the predominant type 2 isoform ) have been approved by the FDA as treatments for hair loss.
Sex hormone binding globulin (SHBG), which is responsible for binding testosterone and preventing its bioavailability and conversion to DHT, is typically lower in individuals with high DHT. SHBG is downregulated by insulin.
Increased levels of Insulin Growth Factor-1 (IGF-1) have been correlated to vertex balding [4]
High insulin levels seem the likely link between metabolic syndrome and baldness. Low levels of SHBG in men and non-pregnant women are also correlated with glucose intolerance and diabetes risk, though this correlation disappears during pregnancy. [5]
Hair loss and lifestyle
While genetic factors play a strong role in the development and progression of androgenetic alopecia, lifestyle also plays a role as demonstrated by the vast increase in male pattern baldness in Japan after World War II.
Daily, vigorous aerobic exercise (as opposed to short workout periods designed to raise androgen levels and build muscle or more sporadic exercise) has been shown to reduce baseline insulin levels as well as baseline total and free testosterone, significantly lowering baseline DHT.[6] It has been suggested that weight training may have a detrimental effect on hair by increasing testosterone levels; however, there is at least one study that indicates a decline in free testosterone as result of weight training.[7]
Treatments
While many people with male pattern baldness choose to accept the condition, there are baldness treatments which can reduce or halt hair loss, and in early stages or rare cases, reverse it entirely. Treatments from most to least effective include:
- Hair transplantation
- Dutasteride
- Finasteride
- Minoxidil
- Ketoconazole
- Saw Palmetto Extract
- Topical Caffeine [8]
References
- ↑ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14758568&query_hl=18
- ↑ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9349747&query_hl=4&itool=pubmed_docsum
- ↑ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16155734&query_hl=36&itool=pubmed_docsum
- ↑ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10025745&query_hl=1&itool=pubmed_docsum
- ↑ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16492215&query_hl=19&itool=pubmed_DocSum
- ↑ http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15618989&query_hl=16&itool=pubmed_docsum
- ↑ Ara, I.; Perez-Gomez, J.; Vicente-Rodriguez, G.; Chavarren, J.; Dorado, C.; Calbet, J. A. L. (2006). "Serum free testosterone, leptin and soluble leptin receptor changes in a 6-week strength-training programme.". British Journal of Nutrition 96 (6): 1053-9.
- ↑ Fischer TW et al (2007). "Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro.". Int J Dermatol. 46(1): 27–35.
Bibliography
External links
- International Society of Hair Restoration Surgery Resources for finding doctors, and more information about hair loss. This is one of the leading organizations in the world on hair loss.
- Medical Treatments for Balding Men: April 1999, American Family Physician (medical journal)
- Commercial treatment reviews Examines hair loss products, and the claims made by their manufacturers.
- How Hair Replacement Works Covers oral medications, hair transplant surgery, and topical treatments.
- Alopecia UK
WikiDoc Research Resources for Androgenic alopecia | |
|---|---|
| Articles on Androgenic alopecia | Most recent articles on Androgenic alopecia • Most cited articles on Androgenic alopecia • Review articles on Androgenic alopecia • Articles on Androgenic alopecia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Androgenic alopecia | Powerpoint slides on Androgenic alopecia • Images of Androgenic alopecia • Photos of Androgenic alopecia • Podcasts & MP3s on Androgenic alopecia • Videos on Androgenic alopecia |
| Evidence Based Medicine Regarding Androgenic alopecia | Cochrane Collaboration on Androgenic alopecia • Bandolier on Androgenic alopecia • TRIP on Androgenic alopecia |
| Cost Effectiveness of Androgenic alopecia | Cost Effectiveness of Androgenic alopecia |
| Clinical Trials Involving Androgenic alopecia | Ongoing Trials on Androgenic alopecia at Clinical Trials.gov • Trial results on Androgenic alopecia • Clinical Trials on Androgenic alopecia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Androgenic alopecia | US National Guidelines Clearinghouse on Androgenic alopecia • NICE Guidance on Androgenic alopecia • NHS PRODIGY Guidance • FDA on Androgenic alopecia • CDC on Androgenic alopecia |
| Textbook Information on Androgenic alopecia | Books and Textbook Information on Androgenic alopecia |
| Pharmacology Resources on Androgenic alopecia | Dosing of Androgenic alopecia • Drug interactions with Androgenic alopecia • Side effects of Androgenic alopecia • Allergic reactions to Androgenic alopecia • Overdose information on Androgenic alopecia • Carcinogenicity information on Androgenic alopecia • Androgenic alopecia in pregnancy • Pharmacokinetics of Androgenic alopecia • |
| Genetics, Pharmacogenomics, and Proteinomics of Androgenic alopecia | Genetics of Androgenic alopecia • Pharmacogenomics of Androgenic alopecia • Proteomics of Androgenic alopecia |
| Newstories on Androgenic alopecia | Androgenic alopecia in the news • Be alerted to news on Androgenic alopecia • News trends on Androgenic alopecia |
| Commentary on Androgenic alopecia | Blogs on Androgenic alopecia |
| Patient Resources on Androgenic alopecia | Patient resources on Androgenic alopecia • Discussion groups on Androgenic alopecia • Patient Handouts on Androgenic alopecia • Directions to Hospitals Treating Androgenic alopecia • Risk calculators and risk factors for Androgenic alopecia |
| Healthcare Provider Resources on Androgenic alopecia | Symptoms of Androgenic alopecia • Causes & Risk Factors for Androgenic alopecia • Diagnostic studies for Androgenic alopecia • Treatment of Androgenic alopecia |
| Continuing Medical Education (CME) Programs on Androgenic alopecia | CME Programs on Androgenic alopecia |
| International Resources on Androgenic alopecia | Androgenic alopecia en Espanol • Androgenic alopecia en Francais |
| Business Resources on Androgenic alopecia | Androgenic alopecia in the Marketplace • Patents on Androgenic alopecia |
| Informatics Resources on Androgenic alopecia | List of terms related to Androgenic alopecia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
